SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: surfinSteve who wrote (246)1/21/1997 10:20:00 PM
From: Art Baer   of 1172
 
Commentary on earnings:
I feel not too impressed by the report but I will underline some good and negative key factors. The products sales do not include Hp Check except milestone payments from Astra Merck (I think). This is good because it means that the milestone payment alone was over 400,000. On the negative side Cholestrek sales fell quarter over quater. But are up over 90% since last year. However, they have been able to reduce product cost. I think time will tell that the HIV test and H. pylri test will help CMTR to pull through.

As Always,

Art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext